|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14 SEK | -3.78% |
|
+2.19% | +76.10% |
| 04-25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 01-29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Arcoma AB reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 46.46 million compared to SEK 37.59 million a year ago. Revenue was SEK 47.41 million compared to SEK 37.94 million a year ago.
Net income was SEK 4.5 million compared to net loss of SEK 2.34 million a year ago. Basic earnings per share from continuing operations was SEK 0.34 compared to basic loss per share from continuing operations of SEK 0.18 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +76.10% | 17.69M | |
| -0.97% | 15.26B | |
| -36.20% | 3.01B | |
| -12.03% | 2.44B | |
| -12.41% | 1.46B | |
| -.--% | 1.12B | |
| +65.15% | 591M | |
| +14.60% | 247M | |
| -2.35% | 231M | |
| +7.96% | 194M |
ARCOMA AB 
